Exchange Bulletin

Titan Medical Inc. (TMD.WT.D) To Trade On Toronto Stock Exchange


March 28, 2014

TITAN MEDICAL INC. ("TMD") ("TMD.WT.D")
BULLETIN TYPE: New Listing-Warrants
BULLETIN DATE: March 27, 2014
TSX Venture Tier 2 Company

Effective at the opening, Friday, March 28, 2014, the warrants of the Company
will commence trading on TSX Venture Exchange. The Company is classified as a 'Medical Devices Manufacturing' company.

Corporate Jurisdiction: Ontario

Capitalization: 9,408,855 warrants with no par value of which
9,408,855 are issued and outstanding

Transfer Agent: Olympia Transfer Services Inc.
Trading Symbol: TMD.WT.D
CUSIP Number: 88830X181

The warrants were issued pursuant to a prospectus offering of 9,142,500 units
(7,950,000 units plus over-allotment option for an additional 1,192,500 units) at $1.40 per unit with 9,142,500 warrants. Each warrant entitles the holder to purchase one common share at a price of $2.00 per common share and will expire on Sunday, February 19, 2017.

An additional 532,710 Broker Warrants were issued pursuant to the Company's
Prospectus offering (accepted by the Exchange March 3, 2014). Of these, 266,355 Broker Warrants have been exercised. Up to an additional 266,355 warrants could be added to the current warrants issued and outstanding in the event the Agent from the Company's Prospectus offering exercises its Broker Warrants. See below for information regarding the Broker Warrants from the Prospectus Offering.

Agent's Fee: Excluding the sale of Units issued to subscribers identified by the company via a 'President's List', the Agent shall receive a fee equal to 6% of the proceeds from Units sold pursuant to the agency agreement between the Company and the Agent, plus compensation warrants ('Broker Warrants') to purchase such number of Units equal to 6% (532,710 Units) of the number of units sold. Each Broker Warrant is exercisable into one common share and one warrant at a price of $1.40 for a period of two years following closing of the Offering. Each subsequent warrant issued on exercise of the Broker Warrant is exercisable into one common share at a price of $2.00 for a period of three years following closing of the Offering.